The New Jersey pharma is tapping Infinimmune to hunt for antibodies for as-of-yet undisclosed targets.
Morbi et tellus imperdiet, aliquam nulla sed, dapibus erat. Aenean dapibus sem non purus venenatis vulputate. Donec accumsan eleifend blandit. Nullam auctor ligula
The New Jersey pharma is tapping Infinimmune to hunt for antibodies for as-of-yet undisclosed targets.